374 related articles for article (PubMed ID: 15831455)
1. FAT10, a ubiquitin-independent signal for proteasomal degradation.
Hipp MS; Kalveram B; Raasi S; Groettrup M; Schmidtke G
Mol Cell Biol; 2005 May; 25(9):3483-91. PubMed ID: 15831455
[TBL] [Abstract][Full Text] [Related]
2. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L.
Schmidtke G; Kalveram B; Groettrup M
FEBS Lett; 2009 Feb; 583(3):591-4. PubMed ID: 19166848
[TBL] [Abstract][Full Text] [Related]
3. FAT10ylation as a signal for proteasomal degradation.
Schmidtke G; Aichem A; Groettrup M
Biochim Biophys Acta; 2014 Jan; 1843(1):97-102. PubMed ID: 23333871
[TBL] [Abstract][Full Text] [Related]
4. NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation.
Hipp MS; Raasi S; Groettrup M; Schmidtke G
J Biol Chem; 2004 Apr; 279(16):16503-10. PubMed ID: 14757770
[TBL] [Abstract][Full Text] [Related]
5. The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition.
Kalveram B; Schmidtke G; Groettrup M
J Cell Sci; 2008 Dec; 121(Pt 24):4079-88. PubMed ID: 19033385
[TBL] [Abstract][Full Text] [Related]
6. The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10.
Schmidtke G; Kalveram B; Weber E; Bochtler P; Lukasiak S; Hipp MS; Groettrup M
J Biol Chem; 2006 Jul; 281(29):20045-54. PubMed ID: 16707496
[TBL] [Abstract][Full Text] [Related]
7. The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation.
Aichem A; Anders S; Catone N; Rößler P; Stotz S; Berg A; Schwab R; Scheuermann S; Bialas J; Schütz-Stoffregen MC; Schmidtke G; Peter C; Groettrup M; Wiesner S
Nat Commun; 2018 Aug; 9(1):3321. PubMed ID: 30127417
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin-like modifier FAT10 inhibits retinal PDE6 activity and mediates its proteasomal degradation.
Boehm AN; Bialas J; Catone N; Sacristan-Reviriego A; van der Spuy J; Groettrup M; Aichem A
J Biol Chem; 2020 Oct; 295(42):14402-14418. PubMed ID: 32817338
[TBL] [Abstract][Full Text] [Related]
9. The NS2 protein generated by the parvovirus minute virus of mice is degraded by the proteasome in a manner independent of ubiquitin chain elongation or activation.
Miller CL; Pintel DJ
Virology; 2001 Jul; 285(2):346-55. PubMed ID: 11437668
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon.
Lukasiak S; Schiller C; Oehlschlaeger P; Schmidtke G; Krause P; Legler DF; Autschbach F; Schirmacher P; Breuhahn K; Groettrup M
Oncogene; 2008 Oct; 27(46):6068-74. PubMed ID: 18574467
[TBL] [Abstract][Full Text] [Related]
11. FAT10 is a proteasomal degradation signal that is itself regulated by ubiquitination.
Buchsbaum S; Bercovich B; Ciechanover A
Mol Biol Cell; 2012 Jan; 23(1):225-32. PubMed ID: 22072791
[TBL] [Abstract][Full Text] [Related]
12. Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
Bialas J; Groettrup M; Aichem A
PLoS One; 2015; 10(3):e0120329. PubMed ID: 25768649
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway.
Bies J; Wolff L
Oncogene; 1997 Jan; 14(2):203-12. PubMed ID: 9010222
[TBL] [Abstract][Full Text] [Related]
14. Analysis of modification and proteolytic targeting by the ubiquitin-like modifier FAT10.
Aichem A; Boehm AN; Catone N; Schmidtke G; Groettrup M
Methods Enzymol; 2019; 618():229-256. PubMed ID: 30850054
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-ovomucoid fusion proteins as model substrates for monitoring degradation and deubiquitination by proteasomes.
Yao T; Cohen RE
Methods Enzymol; 2005; 398():522-40. PubMed ID: 16275356
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin-like modifier FAT10 interferes with SUMO activation.
Aichem A; Sailer C; Ryu S; Catone N; Stankovic-Valentin N; Schmidtke G; Melchior F; Stengel F; Groettrup M
Nat Commun; 2019 Oct; 10(1):4452. PubMed ID: 31575873
[TBL] [Abstract][Full Text] [Related]
17. FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences.
Canaan A; Yu X; Booth CJ; Lian J; Lazar I; Gamfi SL; Castille K; Kohya N; Nakayama Y; Liu YC; Eynon E; Flavell R; Weissman SM
Mol Cell Biol; 2006 Jul; 26(13):5180-9. PubMed ID: 16782901
[TBL] [Abstract][Full Text] [Related]
18. The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.
Bialas J; Boehm AN; Catone N; Aichem A; Groettrup M
J Biol Chem; 2019 Mar; 294(12):4315-4330. PubMed ID: 30718280
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitin-like modifier FAT10 in antigen processing and antimicrobial defense.
Basler M; Buerger S; Groettrup M
Mol Immunol; 2015 Dec; 68(2 Pt A):129-32. PubMed ID: 25983082
[TBL] [Abstract][Full Text] [Related]
20. The ubiquitin-like modifier FAT10 is required for normal IFN-γ production by activated CD8
Mah MM; Basler M; Groettrup M
Mol Immunol; 2019 Apr; 108():111-120. PubMed ID: 30818228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
